LIEN:NASDAQChicago Atlantic BDC, Inc. Analysis
Data as of 2026-05-25 - not real-time
$9.89
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Chicago Atlantic BDC (LIEN) posted a quarterly EPS of $0.44, beating the consensus estimate by 22% and turning a loss year‑over‑year into profit. The company’s revenue surged 40% YoY to $59.1 M, supporting a robust profit margin of 58% and a forward EPS of $1.68. At a trailing P/E of 6.6 versus the industry average of 16.8, the stock trades at a steep discount, while the price‑to‑book of 0.74 is well below its book value of $13.30 per share. A DCF fair value near $39 implies a potential upside of more than 300% relative to the current price of $9.89. However, the balance sheet carries $54.5 M of debt against just $3.3 M of cash, yielding a debt‑to‑equity ratio of 17.9 and a high payout ratio of 91%, raising concerns about dividend sustainability. The stock offers an eye‑catching dividend yield of 13.8%, but operating cash flow is negative ($‑34 M), indicating the dividend is largely funded by external financing.
Technically, the price sits above the 20‑day (9.44) and 50‑day (9.50) moving averages and the MACD histogram is positive, signaling short‑term bullish momentum. RSI at 60.8 suggests the stock is not yet overbought, and volume is trending upward, supporting the recent price gains. Despite the bullish short‑term indicators, the 200‑day average (10.25) remains above price and the computed trend direction is bearish, reflecting longer‑term weakness. Volatility is high at 32% over the past 30 days, while beta 0.18 indicates price swings are largely independent of the broader market. The company operates in the cannabis‑adjacent BDC space, exposing it to medium‑high regulatory risk as policy changes could impact loan performance. Overall, the stock appears undervalued with strong near‑term catalysts but faces significant leverage and dividend‑sustainability headwinds that temper longer‑term optimism.
Technically, the price sits above the 20‑day (9.44) and 50‑day (9.50) moving averages and the MACD histogram is positive, signaling short‑term bullish momentum. RSI at 60.8 suggests the stock is not yet overbought, and volume is trending upward, supporting the recent price gains. Despite the bullish short‑term indicators, the 200‑day average (10.25) remains above price and the computed trend direction is bearish, reflecting longer‑term weakness. Volatility is high at 32% over the past 30 days, while beta 0.18 indicates price swings are largely independent of the broader market. The company operates in the cannabis‑adjacent BDC space, exposing it to medium‑high regulatory risk as policy changes could impact loan performance. Overall, the stock appears undervalued with strong near‑term catalysts but faces significant leverage and dividend‑sustainability headwinds that temper longer‑term optimism.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Quarterly earnings beat and strong revenue growth
- Bullish MACD and price above short‑term SMAs
- Increasing volume supporting momentum
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- High dividend yield but sustainability concerns
- Elevated leverage and debt‑to‑equity ratio
- Medium‑high regulatory risk in cannabis sector
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside from valuation gap
- Long‑term bearish trend and 200‑day average above price
- Continued regulatory and leverage uncertainties
Key Metrics & Analysis
Financial Health
Revenue Growth40.10%
Profit Margin57.89%
P/E Ratio6.6
ROE11.30%
ROA6.52%
Debt/Equity17.92
P/B Ratio0.7
Op. Cash Flow$-34042844
Free Cash Flow$26.6M
Industry P/E16.8
Technical Analysis
TrendBearish
RSI60.8
Support$8.92
Resistance$10.25
MA 20$9.44
MA 50$9.50
MA 200$10.25
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair Value$39.20
Target Price$11.00
Upside/Downside11.22%
GradeUndervalued
TypeBlend
Dividend Yield13.77%
Risk Assessment
Beta0.18
Volatility32.22%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.